Menu

Question 3441

Topic: Biology, Genetics & Bone Healing

A 3-year-old boy presents with progressive bowing of his legs and short stature. Labs show normal serum calcium, normal PTH, low serum phosphorus, and elevated alkaline phosphatase. Which of the following is the most likely pathophysiologic mechanism for his disease?

. Dietary vitamin D deficiency
. Inability to 1-alpha-hydroxylate 25-OH vitamin D
. End-organ resistance to 1,25-(OH)2 vitamin D
. Excessive production or reduced cleavage of FGF-23
. Primary hyperparathyroidism

Correct Answer & Explanation

. Excessive production or reduced cleavage of FGF-23


Explanation

The patient has X-linked hypophosphatemic rickets (XLH), the most common heritable form of rickets. It is caused by a mutation in the PHEX gene leading to elevated levels of Fibroblast Growth Factor 23 (FGF-23). FGF-23 decreases renal tubular reabsorption of phosphate and suppresses 1-alpha-hydroxylase, leading to profound phosphaturia and impaired bone mineralization. Calcium and PTH are typically normal.

Question 3442

Topic: Biology, Genetics & Bone Healing
Which of the following bone morphogenetic proteins (BMPs) is FDA-approved for use as an adjunct in acute, open tibial shaft fractures treated with an intramedullary nail, and functions primarily via potent osteoinduction?
. BMP-2
. BMP-3
. BMP-7
. Transforming Growth Factor-beta (TGF-b)
. Platelet-Derived Growth Factor (PDGF)

Correct Answer & Explanation

. BMP-2


Explanation

BMP-2 (rhBMP-2, available commercially as INFUSE) is highly osteoinductive and is FDA-approved for acute, open tibial shaft fractures and anterior lumbar interbody fusion (ALIF). BMP-7 (OP-1) was previously approved for recalcitrant tibial nonunions under a humanitarian device exemption. BMP-3 actually inhibits bone formation.

Question 3443

Topic: Biology, Genetics & Bone Healing

A 6-year-old boy presents with progressive bowing of the legs and short stature. Laboratory tests show normal serum calcium, profoundly low serum phosphate, normal PTH, and normal 25-hydroxyvitamin D levels. A mutation in the PHEX gene is identified. The primary pathophysiology of his bone disease is driven by the overproduction of:

. Fibroblast growth factor 23 (FGF-23)
. Osteocalcin
. Alkaline phosphatase
. Sclerostin
. Dickkopf-1 (DKK-1)

Correct Answer & Explanation

. Fibroblast growth factor 23 (FGF-23)


Explanation

The patient has X-linked hypophosphatemic rickets, the most common heritable form of rickets. A mutation in the PHEX gene leads to decreased degradation and consequently high circulating levels of FGF-23. FGF-23 inhibits sodium-phosphate cotransporters in the renal proximal tubule, causing renal phosphate wasting.

Question 3444

Topic: Biology, Genetics & Bone Healing

A 32-year-old female is diagnosed with an expansile, lytic Giant Cell Tumor (GCT) in the distal femur. Because the lesion is large and abuts the subchondral bone, she is placed on neoadjuvant denosumab therapy to facilitate joint-salvage surgery. Denosumab functions by binding directly to which of the following?

. RANK receptor
. RANK ligand (RANKL)
. Osteoprotegerin (OPG)
. Vascular endothelial growth factor (VEGF)
. Interleukin-6 (IL-6)

Correct Answer & Explanation

. RANK ligand (RANKL)


Explanation

Denosumab is a fully human monoclonal antibody that binds to RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand). By binding RANKL, it prevents it from interacting with the RANK receptor on the surface of osteoclasts and giant cells, thereby profoundly inhibiting their activation and leading to tumor ossification.

Question 3445

Topic: Biology, Genetics & Bone Healing

A 65-year-old man with progressive cranial enlargement and anterior bowing of his tibiae is diagnosed with Paget's disease of bone. The underlying cellular abnormality involves hyperactive osteoclasts. Familial forms of this condition are most strongly associated with a mutation in which of the following genes?

. COL1A1
. FGFR3
. SQSTM1
. GNAS
. EXT1

Correct Answer & Explanation

. SQSTM1


Explanation

Paget's disease of bone is characterized by chaotic bone remodeling driven by overactive, multinucleated osteoclasts. Approximately 40-50% of familial cases and 10% of sporadic cases are associated with mutations in the SQSTM1 gene, which encodes the p62 protein, leading to increased RANK-NFkB signaling in osteoclasts.

Question 3446

Topic: Biology, Genetics & Bone Healing

A 68-year-old woman is diagnosed with multiple myeloma after presenting with diffuse bone pain and 'punched-out' lytic lesions on radiographs. The profound osteolysis seen in multiple myeloma is predominantly driven by myeloma cell-induced upregulation of which of the following combinations of factors?

. BMP-2 and TGF-beta
. Osteoprotegerin (OPG) and Interleukin-10 (IL-10)
. Macrophage inflammatory protein-1 alpha (MIP-1a) and RANKL
. Sclerostin and Fibroblast Growth Factor 23 (FGF-23)
. Platelet-derived growth factor (PDGF) and Vascular endothelial growth factor (VEGF)

Correct Answer & Explanation

. Macrophage inflammatory protein-1 alpha (MIP-1a) and RANKL


Explanation

Myeloma cells secrete factors such as MIP-1a, IL-3, and IL-6, which heavily upregulate RANKL expression by marrow stromal cells while simultaneously downregulating OPG. This leads to massive osteoclast activation and the characteristic severe lytic bone destruction.

Question 3447

Topic: Biology, Genetics & Bone Healing

A 22-year-old patient presents with recurrent fractures, anemia, and cranial nerve palsies. Radiographs demonstrate diffusely dense bones and a "rugger jersey" spine. The underlying pathophysiology of this condition is most commonly due to a primary defect in which of the following?

. Type I collagen synthesis
. Carbonic anhydrase II
. Osteoprotegerin (OPG) production
. Fibroblast growth factor receptor 3 (FGFR3)
. Mineralization of the osteoid matrix

Correct Answer & Explanation

. Carbonic anhydrase II


Explanation

Osteopetrosis is characterized by defective osteoclast function, preventing normal bone resorption. This is most frequently due to a mutation in the carbonic anhydrase II gene or TCIRG1, disrupting the acidification of the subosteoclastic Howship's lacunae.

Question 3448

Topic: Biology, Genetics & Bone Healing

A 55-year-old female presents with diffuse, dull bone pain and proximal muscle weakness. Laboratory studies reveal low serum calcium, low serum phosphate, elevated alkaline phosphatase, and elevated parathyroid hormone (PTH). Radiographs show bilateral pseudofractures in the femoral neck. What is the most likely diagnosis?

. Osteoporosis
. Paget's disease of bone
. Osteomalacia
. Renal osteodystrophy
. Primary hyperparathyroidism

Correct Answer & Explanation

. Osteomalacia


Explanation

Osteomalacia is characterized by defective mineralization of osteoid, typically caused by severe vitamin D deficiency. The classic laboratory profile shows secondary hyperparathyroidism with low or normal calcium/phosphate and elevated alkaline phosphatase, alongside radiographic Looser zones (pseudofractures).

Question 3449

Topic: Biology, Genetics & Bone Healing

A 68-year-old woman with severe osteoporosis is treated with denosumab. This biologic agent exerts its anti-resorptive effect by binding directly to which of the following molecular targets?

. RANK receptor
. RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand)
. Osteoprotegerin (OPG)
. Macrophage colony-stimulating factor (M-CSF)
. Sclerostin

Correct Answer & Explanation

. RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand)


Explanation

Denosumab is a human monoclonal antibody that specifically binds to and inhibits RANKL. By neutralizing RANKL, it prevents interaction with the RANK receptor on osteoclast precursors, thereby halting osteoclast maturation, function, and survival.

Question 3450

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs), particularly BMP-2 and BMP-7, are utilized to augment fracture healing and spinal fusions. These osteoinductive proteins primarily exert their cellular effects by signaling through which of the following intracellular pathways?

. Wnt/beta-catenin pathway
. JAK/STAT pathway
. Smad 1/5/8 pathway
. MAPK/ERK pathway
. Notch signaling pathway

Correct Answer & Explanation

. Smad 1/5/8 pathway


Explanation

BMPs bind to heterodimeric serine/threonine kinase receptors on the cell surface. This activates an intracellular signaling cascade primarily mediated by the phosphorylation of Smad 1, 5, and 8 proteins, which then translocate to the nucleus to regulate target gene expression.

Question 3451

Topic: Biology, Genetics & Bone Healing

An 80-year-old female with severe osteoporosis is started on teriparatide therapy. This medication, administered as a daily subcutaneous injection, increases bone mineral density primarily through which of the following mechanisms?

. Stimulating osteoblast differentiation and inhibiting osteoblast apoptosis
. Directly binding to osteoclasts to inhibit their resorptive function
. Increasing renal excretion of calcium and phosphate
. Blocking the synthesis of 1,25-dihydroxyvitamin D
. Downregulating the canonical Wnt/beta-catenin pathway

Correct Answer & Explanation

. Stimulating osteoblast differentiation and inhibiting osteoblast apoptosis


Explanation

While continuous parathyroid hormone (PTH) exposure promotes bone resorption, intermittent administration of PTH analogs like teriparatide has a robust anabolic effect. It acts directly on osteoblasts to stimulate their differentiation, increase their activity, and significantly inhibit osteoblast apoptosis.

Question 3452

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory, what is the maximum amount of interfragmentary strain that allows for primary bone healing to occur without callus formation?

. < 2%
. 2-10%
. 10-30%
. 30-50%
. > 50%

Correct Answer & Explanation

. < 2%


Explanation

Primary bone healing (cutting cone remodeling) occurs under conditions of absolute stability, requiring an interfragmentary strain of less than 2%. Strains between 2% and 10% promote secondary bone healing via callus formation.

Question 3453

Topic: Biology, Genetics & Bone Healing

A 45-year-old woman with a history of Roux-en-Y gastric bypass presents with diffuse bone pain and proximal muscle weakness. Laboratory evaluation reveals low serum calcium, low phosphorus, elevated alkaline phosphatase, and elevated parathyroid hormone (PTH). What is the most likely diagnosis?

. Primary hyperparathyroidism
. Osteoporosis
. Osteomalacia
. Paget's disease
. Renal osteodystrophy

Correct Answer & Explanation

. Osteomalacia


Explanation

The patient has severe vitamin D deficiency secondary to malabsorption, leading to osteomalacia. This causes hypocalcemia, which stimulates secondary hyperparathyroidism, subsequently lowering serum phosphorus through renal excretion.

Question 3454

Topic: Biology, Genetics & Bone Healing

A 30-year-old woman is diagnosed with an expansive, eccentrically located, lytic lesion in the distal femur extending to the subchondral bone. Biopsy confirms a Giant Cell Tumor of bone. If medical therapy is considered, which molecular pathway is targeted to inhibit the progression of this tumor?

. VEGF inhibition
. RANKL inhibition
. mTOR inhibition
. Tyrosine kinase inhibition
. PD-1 inhibition

Correct Answer & Explanation

. RANKL inhibition


Explanation

Giant cell tumors of bone consist of neoplastic stromal cells that express RANKL, which recruits and activates the reactive osteoclast-like giant cells. Denosumab, a monoclonal antibody against RANKL, is used for unresectable or recurrent cases.

Question 3455

Topic: Biology, Genetics & Bone Healing

A 4-year-old girl is evaluated for recurrent fractures with minimal trauma. Examination reveals blue sclerae and mild hearing loss. A defect in which of the following processes is primarily responsible for her condition?

. Mineralization of osteoid
. Proliferation of chondrocytes
. Glycosylation of procollagen
. Assembly of triple helix of type 1 collagen
. Osteoclast-mediated bone resorption

Correct Answer & Explanation

. Assembly of triple helix of type 1 collagen


Explanation

Osteogenesis imperfecta is most commonly caused by autosomal dominant mutations in the COL1A1 or COL1A2 genes, which disrupt the assembly of the type I collagen triple helix. This results in brittle bones, blue sclerae, and early-onset hearing loss.

Question 3456

Topic: Biology, Genetics & Bone Healing

A surgeon utilizes demineralized bone matrix (DBM) during a spinal fusion. Which of the following properties does DBM inherently possess to facilitate bone formation?

. Osteoconductive and osteoinductive
. Osteoconductive and osteogenic
. Osteoinductive and osteogenic
. Osteoconductive only
. Osteogenic only

Correct Answer & Explanation

. Osteoconductive and osteoinductive


Explanation

Demineralized bone matrix (DBM) provides a collagenous structural scaffold (osteoconductive) and retains bone morphogenetic proteins (BMPs) that stimulate local cells to differentiate into bone-forming cells (osteoinductive). However, it lacks viable cells, so it is not osteogenic.

Question 3457

Topic: Biology, Genetics & Bone Healing

A 4-year-old boy presents with a history of recurrent fractures, blue sclerae, and early-onset hearing loss. A structural defect in which of the following molecular processes is the primary pathophysiology?

. Defective mineralization of osteoid
. Abnormal endochondral ossification
. Impaired hydroxylation of proline
. Substitution of glycine in the collagen triple helix
. Overactivity of osteoclast remodeling

Correct Answer & Explanation

. Substitution of glycine in the collagen triple helix


Explanation

The patient has Osteogenesis Imperfecta (OI), which is most commonly caused by an autosomal dominant point mutation in the COL1A1 or COL1A2 genes. This results in the substitution of glycine by a bulkier amino acid in the procollagen triple helix, disrupting Type I collagen assembly.

Question 3458

Topic: Biology, Genetics & Bone Healing

A 65-year-old man presents with increasing hat size and bilateral hip pain. Radiographs reveal extensive cortical thickening and coarsened trabeculae. Bone biopsy demonstrates a mosaic pattern of lamellar bone. What is the primary cellular defect initiating this condition?

. Decreased osteoblast activity
. Increased osteoblast activity
. Decreased osteoclast activity
. Increased osteoclast activity
. Impaired osteocyte mechanotransduction

Correct Answer & Explanation

. Increased osteoclast activity


Explanation

Paget disease of bone is initiated by an intense phase of overactive, increased osteoclastic bone resorption (the lytic phase), followed by disorganized osteoblastic bone formation. The resulting woven bone has a characteristic 'mosaic' or 'jigsaw puzzle' appearance on histology.

Question 3459

Topic: Biology, Genetics & Bone Healing

A 5-year-old boy is diagnosed with X-linked hypophosphatemic rickets. Which of the following laboratory profiles is most characteristic of his untreated condition?

. Normal calcium, decreased phosphate, normal PTH, elevated FGF23
. Decreased calcium, normal phosphate, elevated PTH, normal FGF23
. Elevated calcium, decreased phosphate, decreased PTH, normal FGF23
. Normal calcium, elevated phosphate, normal PTH, decreased FGF23
. Decreased calcium, decreased phosphate, elevated PTH, elevated FGF23

Correct Answer & Explanation

. Normal calcium, decreased phosphate, normal PTH, elevated FGF23


Explanation

X-linked hypophosphatemic rickets (XLH) is caused by a PHEX gene mutation that leads to excess Fibroblast Growth Factor 23 (FGF23). Elevated FGF23 causes renal phosphate wasting, leading to hypophosphatemia. Serum calcium and Parathyroid Hormone (PTH) levels are typically normal.

Question 3460

Topic: Biology, Genetics & Bone Healing

A 30-year-old woman presents with a lytic, epiphyseal-metaphyseal lesion in her proximal tibia. Biopsy reveals multinucleated giant cells intermixed with mononuclear stromal cells. Systemic therapy with denosumab is considered. What is the specific target of this medication?

. VEGF
. RANKL
. mTOR
. Tyrosine kinase
. PD-1

Correct Answer & Explanation

. RANKL


Explanation

Giant cell tumor of bone is driven by neoplastic mononuclear stromal cells that express high levels of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL). Denosumab is a monoclonal antibody that targets RANKL, preventing the recruitment and activation of the destructive multinucleated giant cells.